Target intelligence / Profile preview

Teneurin transmembrane protein 2 (TENM2)

Target
TENM2
Molecular classification
Cell adhesion molecule, Type II transmembrane protein, Receptor (ligand for latrophilin/ADGRL family), Nerve tissue protein, Membrane protein
01

Overview

Teneurin transmembrane protein 2 (TENM2) is a large cell-surface adhesion protein essential for proper neural development, particularly in regulating axon guidance, neuronal migration, and synaptic connectivity in the central nervous system[1][2][3]. TENM2 is a type II transmembrane protein, containing an N-terminal cytoplasmic region, a single transmembrane span, and a large, structurally complex extracellular region with EGF-like repeats, an immunoglobulin-like domain, and a toxin-like β-barrel domain[1][3]. It functions as a ligand for the latrophilin family of transmembrane GPCRs (particularly ADGRL1 and ADGRL3), mediating heterophilic cell-cell adhesion and facilitating retrograde synaptic signaling[1][2][3]. TENM2 is broadly expressed across neuronal and other tissues and has been linked to various neural developmental processes and disease phenotypes, although it is not yet a direct clinical drug target. Its multi-domain architecture and regulated splicing underlie diverse roles in embryogenesis, signal transduction, and tissue patterning[1][3][2].

Other names
Teneurin-2Ten-2TEN2ODZ2KIAA1127Ten-m2Ten-2 ICDTen-M2TNM2neurestin alphaodd Oz/ten-m homolog 2protein Odd Oz/ten-m homolog 2tenascin-M2
02

Mechanism of action

Not established due to lack of known interacting drugs. Potential mechanism: modulation of cell-cell adhesion, synaptic formation, or axon guidance by targeting TENM2's extracellular domains or its interaction with latrophilin-type GPCRs

03

Biological functions

Cell adhesionAxon guidanceNeural developmentFormation of filopodia and growth cone in neuronal cellsRegulation of synaptic connectivityTrans-synaptic signalingCellular signal transductionGene transcription inhibition (intracellular domain)
04

Disease associations

Deafness, nonsyndromic sensorineuralMitochondrial disordersSkin disorders (peeling skin syndrome 4)Neuronal migration defectsNeurodevelopmental disordersPossibly implicated in psychiatric/neurological disorders (e.g. schizophrenia, Parkinson’s disease, essential tremor, bipolar disorder, anosmia)

Beyond the preview

Go deeper on Teneurin transmembrane protein 2 (TENM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Teneurin transmembrane protein 2 (TENM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call